Xeltis
Netherlands - EindhovenBiotechnology
Focus: Xeltis is a tissue engineering biotech company based in Eindhoven, Netherlands, founded in 2016, developing regenerative medical devices for cardiovascular, nephrology, and women's health applications. The company is publicly traded and currently focused on commercializing bioabsorbable implants and vascular access solutions.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
6-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Xeltis?
AI assessmentXeltis offers innovation-focused early-stage device development with genuine pipeline catalysts, but significant revenue cliff risk and small scale limit job security and growth trajectory for most career stages.
Why Work Here
- Pioneering tissue engineering platform with multiple clinical-stage programs in high-need therapeutic areas (congenital heart disease, end-stage renal disease, peripheral artery disease)
Data completeness
6/9 — Partial
Company HealthWatch
Pipeline
Early-stage
12 total
LOE Risk
1 imminent
BALCOLTRA
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$2MStable
Peak4.9yr
Core revenue driver generating 69% of company sales, but faces 5-year patent cliff with limited late-stage pipeline to offset erosion.
Help build intelligence for Xeltis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.